A genetic test for hereditary breast and ovarian cancer

BRACAnalysis® assesses a woman's risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes. This test has become the standard of care in identification of individuals with hereditary breast and ovarian cancer and is reimbursed by insurance.

Please visit the myriadtests.com website to learn more about inherited breast and ovarian cancer.

Related Links

• Find a Doctor - Search for a doctor by state.
• Cancer History Guide - An online family cancer history tool.
• Hereditary Cancer Quiz - Check your hereditary cancer risk.
• Mutation Prevalence Tables for BRCA1/2 Genes
  
  
• Myriadtests.com Website for Consumers
• Myriadtests.com Website for Healthcare Professionals